MoneyWorks4Me

Ajanta Pharma informs about outcome of board meeting

27 Jul 2023 Evaluate
Ajanta Pharma has informed that Board of Directors of Company have at their meeting held on 27th July 2023, considered and approved the following: Unaudited Consolidated and Standalone Financial Results of the Company for the quarter ended 30b June 2023; 1st interim dividend of Rs 315 cr. for the year FY 2024. It translates into Rs. 25 per share (1250%) on face value of Rs 2 per share. This total dividend of Rs. 25 per share includes a regular dividend of Rs. 10 per share, and an additional Rs 15 per share, distributed as a special dividend on the commemoration of 50 years of momentous journey of the Company; Fixed Friday, 4th August 2023 as the Record date for payment of interim dividend and special dividend. Dividend will be paid on or after 11st August 2023.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..